Clinical Trials Browser

Phase 4 × Osteoporosis × Zoledronic Acid × Clear all

NCT00063609 2017-09-13

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Phase 4 Completed

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms